Docoh
Loading...

250 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q3
PRPO Precipio Inc
12 Nov 21
Quarterly report
4:02pm
misdiagnosis. In support of our platform, we also operate a research and development facility in Omaha, Nebraska which focuses on the development … of cancer misdiagnosis. In support of this platform, we also operate a research and development facility in Omaha, Nebraska which focuses
10-Q
2021 Q2
PRPO Precipio Inc
12 Aug 21
Quarterly report
4:07pm
and aim to solve the growing problem of cancer misdiagnosis. In support of our platform, we also operate a research and development facility … of cancer diagnostics and aim to solve the growing problem of cancer misdiagnosis. In support of this platform, we also operate a research
10-Q
2021 Q1
PRPO Precipio Inc
14 May 21
Quarterly report
4:01pm
of cancer misdiagnosis. In support of our platform, we also operate a research and development facility in Omaha, Nebraska which focuses … of this platform, we also operate a research and development facility in Omaha, Nebraska which focuses on the development of various technologies, among them our
424B5
PRPO Precipio Inc
2 Apr 21
Prospectus supplement for primary offering
2:00pm
a research and development facility in Omaha, Nebraska which focuses on the development of various technologies, among them our internally developed … , including to support research and development, including clinical trials. However, we have not determined the specific allocation of the net proceeds
10-K
2020 FY
PRPO Precipio Inc
29 Mar 21
Annual report
4:29pm
care quality outcomes; promotes a more integrated health care delivery system and the creation of new health care delivery. Research and Development … Expenses For the years ended December 31, 2020 and 2019, we recorded $1.2 million, respectively, of research and development expenses. More information
10-Q
ylhb919v 5r
13 Nov 20
Quarterly report
4:01pm
10-Q
q0wi38wlyr49g9buo31m
13 Aug 20
Quarterly report
3:07pm
424B3
l9drvww
7 Jul 20
Prospectus supplement
5:27pm
S-1
nma7v ggr8kkm8b52
26 Jun 20
IPO registration
5:18pm
10-Q
zd9fv01g
14 May 20
Quarterly report
4:05pm
424B3
e0yvlbeq
13 Apr 20
Prospectus supplement
4:55pm
S-3/A
0eyl2om6cs1ey3ju6azu
9 Apr 20
Shelf registration (amended)
1:53pm
S-1/A
bxsi2b p7pt3
8 Apr 20
IPO registration (amended)
3:41pm
S-3
vg05zw
27 Mar 20
Shelf registration
4:51pm
S-1
poav32 ooklb6a1
27 Mar 20
IPO registration
4:31pm
10-K
u1ml4ku4n8oyd
27 Mar 20
Annual report
3:47pm
424B3
x4tyoqgzx504z3cfvx8
30 Jan 20
Prospectus supplement
5:09pm
S-1/A
slxdlf nz
27 Jan 20
IPO registration (amended)
4:47pm
S-1
gzkv5a7 07c2y
14 Jan 20
IPO registration
4:26pm
10-Q
vzbb5ys
13 Nov 19
Quarterly report
4:33pm